Blogs about: Degarelix
Featured Blog
Understanding the potential of degarelix (and the risks)
A review article and three different sets of editorial comments have just been published in Oncology. They lay out the opinions of several specialists on the potential uses of degarelix — a rece… more →
THE "NEW" PROSTATE CANCER INFOLINK
New prostate cancer drug performs well in suppressing testosterone and PSA
Jim Tucker wrote 2 days ago: JULY 16: URO TODAY: For testosterone suppression and PSA decline, new treatment degarelix compares w … more →
PROSTATE DRUG: Too early to assess use of degarelix
Jim Tucker wrote 4 weeks ago: JUNE 19: NEW PROSTATE CANCER INFOLINK: It may be too early to make decisions about the real clinical … more →
Understanding the potential of degarelix (and the risks)
Sitemaster wrote 4 weeks ago: A review article and three different sets of editorial comments have just been published in Oncology … more →
Phase III trial of intermittent degarelix therapy to be started
Sitemaster wrote 2 months ago: Ferring Pharmaceuticals has announced the company’s intent to initiate a randomized, controlle … more →
PROSTATE TREATMENT: FDA approves new testosterone-suppressing drug
Jim Tucker wrote 2 months ago: ADVANCEWEB.COM: Degarelix, a new drug for treatment of prostate cancer, has gained FDA approval. A … more →
The Thursday news report: March 5, 2009
— 3 comments
Sitemaster wrote 4 months ago: There are a significant number of relatively long-term news items in today’s report. Of most i … more →
Degarelix receives final approval for marketing in Europe
Sitemaster wrote 4 months ago: We reported last December that the Committee for Medicinal Products for Human Use had adopted a posi … more →
Developing New Options for Prostate Cancer Patients
AllenCaron wrote 6 months ago: New options for prostate cancer made headlines this week with the U.S. Food and Drug Administration … more →
Degarelix also approved for marketing in the USA
Sitemaster wrote 6 months ago: We had previously noted the approval of degarelix in Europe on December 23rd. It has been kindly poi … more →
Degarelix recommended for approval in Europe
Sitemaster wrote 6 months ago: Several media reports from earlier in the day state that the Committee for Medicinal Products for Hu … more →
Efficacy and safety of the LHRH antagonist degarelix
Sitemaster wrote 7 months ago: Klotz et al. have now published the complete results of one of the Phase III clinical trials designe … more →
Wednesday's news: October 15, 2008
Sitemaster wrote 9 months ago: There is a significant number of new reports today, addressing such issues as: data from a large ser … more →
Management of advanced prostate cancer: can we improve on androgen deprivation therapy?
Sitemaster wrote 1 year ago: An article with this title, just published in the British Journal of Urology, addresses the potentia … more →
Have your say. Start a blog.
See our free features →
An 
Brainchild
